Jan Drappatz

154 papers receiving 7.0k citations

Jan Drappatz's Hit Papers

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients 2007 · 1.5k citations
1.5k0+6+12Years since publication4008001.2k

Peers

Jan Drappatz
Comparison fields: 5 of 127
  • Genetics 3.4k
  • Cancer Research 1.4k
  • Neurology 1.1k
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 1.2k
Replace Randy L. Jensen with:
Randy L. Jensen United States
Annick Desjardins United States
Ryo Nishikawa Japan
H. Ian Robins United States
Jeffrey J. Raizer United States
Uri Tabori Canada
Olivier Chinot France
Xiaobu Ye United States
Andrew D. Norden United States
Frank Saran United Kingdom
Jan Drappatz relative to Randy L. Jensen United States Randy L. Jensen's profile →
Citations per field
00.5×1.5×
Randy L. Jensen · 1×
Citations per year

Countries citing papers authored by Jan Drappatz

Since Specialization
Citations

This map shows the geographic impact of Jan Drappatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Drappatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Drappatz more than expected).

Fields of papers citing papers by Jan Drappatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Drappatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Drappatz. The network helps show where Jan Drappatz may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Drappatz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Drappatz Line = papers co-authored together Jan Drappatz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.

#Work
1
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Hit paper breakdown →
20071474
2 2010434
3 2014207
4 2009204
5 2008204
6 2013156
7 2006149
8 2009146
9 2006142
10 2010140
11 2008140
12 2012138
13 2010132
14 2008124
15 2008121
16 201299
17 200797
18 201295
19 201790
20 201588

About Jan Drappatz

Jan Drappatz is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Neurology and Molecular Biology, having authored 161 papers that have together received 7.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (98 papers), Brain Metastases and Treatment (26 papers), Cancer, Hypoxia, and Metabolism (17 papers), Meningioma and schwannoma management (16 papers), Cancer Treatment and Pharmacology (14 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Histone Deacetylase Inhibitors Research (11 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Genetics (3.4k citations), Cancer Research (1.4k citations), Neurology (1.1k citations), Oncology (1.2k citations) and Pulmonary and Respiratory Medicine (1.2k citations). Jan Drappatz has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Patrick Y. Wen, Andrew D. Norden, Santosh Kesari, Tracy T. Batchelor, Lisa Doherty, Scott R. Plotkin, David Schiff, Dan G. Duda, A. Gregory Sorensen and Marek Ancukiewicz. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology, Neuro-Oncology, Neurology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact